Elsevier

The Journal of Nutrition

Volume 140, Issue 11, November 2010, Pages 2014-2019
The Journal of Nutrition

Bovine Glycomacropeptide Has Intestinal Antiinflammatory Effects in Rats with Dextran Sulfate-Induced Colitis, ,

https://doi.org/10.3945/jn.109.118448Get rights and content
Under an Elsevier user license
open archive

Abstract

Milk κ-casein-derived bovine glycomacropeptide (GMP) has immunomodulatory and bacterial toxin-binding effects, and it has been shown to exert intestinal antiinflammatory activity in the trinitrobenzenesulfonic acid-induced model of colitis. However, its mechanism of action is not well characterized, and it is not known whether GMP is effective in other experimental models. The intestinal antiinflammatory activity of GMP was assessed in the dextran sulfate sodium (DSS)-induced model of rat colitis. DSS was applied at a starting concentration of 5% (wt:v) in drinking water and adjusted when the disease activity index (DAI) increased substantially for 10 d. There were 3 experimental groups: control (no inflammation), DSS, and GMP (GMP-treated rats with DSS-induced colitis). GMP pretreatment (500 mg · kg−1 · d−1, starting 2 d before DSS treatment) reduced the DAI by 60% and lowered the colonic damage score by 44% (P < 0.05). GMP fully normalized the colonic expression of interleukin (IL) 1β, IL17, IL23, IL6, transforming growth factor β, IL10, and Foxp3 as assessed by quantitative RT-PCR. The production of interferon-γ by mesenteric lymph node cells ex vivo was also normalized by GMP treatment. In contrast, GMP did not change colonic thickening, myeloperoxidase, cyclooxygenase 2, or alkaline phosphatase. Histology analysis showed better preservation of the epithelium and attenuated infiltration and submucosal thickening in rats treated with GMP. We conclude that GMP exerts intestinal antiinflammatory activity in this model, which may be primarily related to actions on Th1 and Th17 lymphocytes and perhaps macrophages.

Abbreviations used:

AP
alkaline phosphatase
ConA
concanavalin A
COX2
cyclooxygenase 2
DAI
disease activity index
DSS
dextran sulfate sodium
GMP
glycomacropeptide
IBD
inflammatory bowel disease
IFN
interferon
IL
interleukin
MLN
mesenteric lymph node
MPO
myeloperoxidase
NF-κB
nuclear factor β transforming growth factor β
TNBS
trinitrobenzenesulfonic acid
TNFα
tumor necrosis factor-α

Cited by (0)

1

Supported by grants from the Instituto de Salud Carlos III (PI051625 and PI051651) and the Ministry of Science and Innovation (SAF2008-01432 and AGL2008-04332). Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) is funded by the Instituto de Salud Carlos III. R.L-P. and P.R. are funded by the Ministry of Science and Innovation. R.G. is funded by CIBERehd. The group is a member of the Network for Cooperative Research on Membrane Transport Proteins, cofunded by the Ministerio de Educación y Ciencia, Spain and the European Regional Development Fund (grant no. BFU2007-30688-E/BFI).

2

R. López-Posadas, P. Requena, R. González, M. D. Suárez, A. Zarzuelo, F. Sánchez de Medina, and O. Martínez-Augustin, no conflicts of interest.

3

Supplemental Figure 1 is available with the online posting of this paper at jn.nutrition.org.